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LABORATORY INVESTIGATION
Induction, characterization, and cell transfer of autoimmune
tubulointerstitial nephritis
KYM M. BANNISTER, THOMAS R. ULICH, and CURTIS B. WILSON
Department of Immunology, Research Institute of Scripps Clinic, 10666 North Torrey Pines Road, La Jolla, California, USA
Induction, characterization, and cell transfer of autoimmune tubuloin-
terstitial nephritls. Autoimmune tubulointerstitial nephritis (TIN) was
induced in Lewis (LEW) rats by immunization with homologous
Brown—Norway (BN) rat renal basement membrane (RBM), complete
Freund's adjuvant and Bordetella pertussis vaccine. The BN strain has
a tubular basement membrane (TBM) antigen (Ag) detectable by
immunofluorescence which is lacking in unmodified LEW rat TBM.
Development of TIN in LEW rats correlated with TBM Ag immuno-
gens from homologous and heterologous RBM preparations. By day 14
after immunization TIN developed characterized by elevated serum
creatinine levels and by tubular destruction with focal, circumscribed
lesions containing epithelioid cells, giant cells and mononuclear cell
infiltrates. Approximately 60% of the mononuclear cells bore T cell
antigens with most cells expressing Ia markers. Immunofluorescence
and elution studies revealed no selective IgG fixation to TBM at day 14
despite high titers of circulating alloantibody reactive with the immu-
nizing TBM. Intravenous transfer of LNC andlor splenic cells (3.5 to 7
x 108) to naive LEW rats resulted in less severe but histologically
identical TIN in seven days with T cell subpopulations similar to those
seen in the active model. This model strongly suggests an initiating role
for cell—mediated immunity in TIN in the rat and may provide a parallel
to human TIN.
Models of autoimmune tubulointerstitial nephritis (TIN) have
been induced in guinea pigs and Brown Norway (BN) rats by
immunization with heterologous or homologous renal basement
membrane (RBM) and adjuvants. These models develop within
1 to 2 weeks after immunization and are characterized by 1)
anti-tubular basement membrane (TBM) antibody formation, 2)
linear fixation of IgG to TBM, and 3) mononuclear cellular
infiltrates dominated by T helper cells in the rat, suggesting
possible roles for both humoral and cell—mediated immunity
[reviewed in 1 and 2]. It is possible to transfer elements of the
TIN in guinea pigs and BN rats with antibody [3—5]. Intrave-
nous transfer of immune cells has failed to reproduce the lesions
of TIN in either species [6—8], although mild lesions of TIN
followed subcapsular transfer of cells in BN rats [9]. The TIN of
BN rats immunized with bovine TBM and adjuvants can be
transferred using lymph node cells propagated with antigen and
a source of interleukin 2; however, interpretation of cellular
events is complicated by the presence of anti-TBM antibody in
recipient kidneys [7]. Evidence provided by Neilson, Phillips
and Jiminex based on an in vitro demonstration of renal
cytotoxic and modulatory lymphocyte subsets supports a role
for cell—mediated immunity in the guinea pig [10—13], and the
same laboratory has reported the modulatory role of a nonspe-
cific suppressor T cell mechanism in TIN in BN rats immunized
with rabbit TBM and adjuvants [14]. Anti-TBM antibody—as-
sociated TIN in the mouse evolves slowly (6 to 8 weeks) and is
reported to be related to H-2 phenotypic traits other than the
magnitude of the anti-TBM antibody response [15]. An Lyt2
effector cell induced by a L3T4 helper T cell line is involved
[16], with antibody transfer producing a somewhat different
lesion than cell transfer [6, 17, 18].
In the rat, the development of anti-TBM antibody—associated
TIN is strain dependent and relates to the presence of a TBM
antigen (TBM Ag) detected by binding of anti-TBM antibody
by immunofluorescence [19]. The Lewis (LEW) rat is TBM Ag
and, although responding to heterologous TBM immunization
with the production of anti-TBM antibody, fails to bind this
antibody to the kidney [19, 20]. Sugisaki et al have described
mild cellular infiltrates in the LEW rat in the absence of fixed
anti-TBM antibody after immunization with syngeneic kidney
homogenate. Adoptive transfer of immune cells into naive
LEW recipients produced mild lesions within 48 hours after
injection, suggesting a cell—mediated mechanism involving au-
tologous antigens [21]. To study the importance of cellular
mechanisms in initiating TIN in the rat, we developed a new
model of TIN in the TBM Ag LEW rat by immunization with
TBM Ag homologous RBM and adjuvants. The immunized
LEW rats developed an unique and severe TIN within 14 days,
transferable by immune cells to naive LEW rats.
Methods
Animals
LEW and BN rats (150 to 200 g) were obtained from the
Research Institute of Scripps Clinic breeding colony, Harlan—
Sprague Dawley (Indianapolis, Indiana, USA), or Trudeau
Institute (Saranac Lake, New York, USA). Normal rat kidneys
of other strains [F344, LBNF1, Sprague Dawley (SD), Ad,
Buffalo (Buff), Wistar Kyoto (WK), Wistar Munich (WM), and
Wistar Furth (WF)] were obtained snap—frozen from Biotrol,
Inc. (Indianapolis, Indiana, USA).
Received for publication February 11, 1987
and in revised form June 16, 1987
© 1987 by the International Society of Nephrology
Antigen preparation and immunization procedures
Rat as well as bovine, rabbit, or human kidney was stripped
of capsule, homogenized (Sorvall, Newtown, Connecticut, USA),
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and sonicated. After centrifugation (1000 x g), the resulting
pellet of renal basement membrane (RBM) was washed and
resonicated repeatedly (7 to 8 cycles) until the supernatant was
visually clear of debris. The pellet was lyophilized and stored at
—30°C until used. For blast transformation assays, RBM was
prepared by the above method under sterile conditions. Colla-
genase solubilization was performed as previously described
[22].
Rats were immunized with 4 mg of RBM (except in dose—
response experiments), emulsified in complete Freund's adju-
vant (CFA) containing 4 mg of Mycobacterium tuberculosis
H37Ra (Difco Labs, Detroit, Michigan, USA) per animal. In
addition, all animals received 0.1 ml of Bordetella pertussis
vaccine (Massachusetts Public Health Biologics Lab, Boston,
Massachusetts, USA) containing approximately 22.2 x i0
cells/mI in a separate injection. Control rats received 0.2 mg of
ovalbumin (Ova) in CFA together with pertussis vaccine.
Morphologic and immunopathologic studies
The gross appearance of the kidneys was noted at either
nephrectomy or sacrifice and portions of the kidneys were fixed
in Bouin's solution. Histologic examination was performed on
paraffin sections stained with the periodic—acid Schiff reaction
and hematoxylin counterstain. In adoptive transfer experi-
ments, TIN was scored after histologic examination of 10 step
kidney sections. The extent and severity of TIN was graded on
a scale of 0 to 5: 0 = no lesions; 1.0 = very small, focal cellular
infiltrates; 2.0 = several focal areas of infiltrate involving less
than 10% cortex; 3.0 = more extensive focal areas involving 10
to 20% cortex; 4.0 = focal areas involving 20 to 30% of cortex
with some macroscopically visible nodules; 5.0 = macroscopi-
cally visible nodules covering over 30% of the kidney surface.
Immunofluorescence (IF) microscopy was performed on snap—
frozen kidney sections stained with fluoresceinated rabbit anti-
rat IgG and anti-rat C3 (Cappel Laboratories, Downington,
Pennsylvania, USA), and was graded on a scale of 0 to 3+.
Elution studies
Kidneys were weighed, homogenized, and washed in PBS
until the supernatant was clear. The homogenate was eluted in
citrate buffer 0.02 M, pH 3.2 [231.
Functional studies
Twenty—four hour urinary protein excretion was measured
using the sulfosalicylic acid method [24] and glycosuria as-
sessed with N-Multistix strips (Miles Labs, Elkhardt, Indiana,
USA). Serum creatinine levels were measured using a commer-
cial creatinine kit (Sigma Diagnostics, St. Louis, Missouri,
USA).
The humoral immune response in LEW rats immunized with
RBM and adjuvant
Indirect IF. Dilutions of serum or eluates were overlaid on
normal BN or LEW rat kidney sections and fluoresceinated
anti-rat IgG was used as the second antiserum.
Radioimmunoassay (RIA). Solid phase RIA [22] was used to
quantitate the reactivity of serum or eluates with particulate BN
or LEW RBM or collagenase solubilized (CS) BN or LEW
RBM. Serum samples were each tested in three serial log
dilutions in triplicate and results were expressed as counts per
minute and compared with those from nonimmunized rats.
To examine the specificity of LEW antibodies to RBM,
inhibition studies were performed. Pooled sera from BN RBM
immunized LEW rats at an appropriate dilution (determined in
preliminary studies) were incubated with increasing amounts of
various lyophilized RBM preparations (/Lg dry weight) over-
night at 4°C with shaking. After centrifugation at 2800 x g, the
supernatant was tested by solid phase RIA using BN-CS RBM
antigen.
Serum and eluate IgG content was determined by solid phase
RIA using known amounts of rat IgG to construct a standard
curve [22].
The cellular immune response in LEW rats immunized with
BN RBM and adjuvants
Blast transformation assay of lymph node cells (LNC). Cells
from draining lymph nodes from individual LEW rats immu-
nized 14 days previously with BN RBM and adjuvants were
prepared under sterile conditions by teasing the nodes with
tissue rakes and pushing through a wire mesh. Blast transfor-
mation assays were performed as previously described [7] in the
presence of either saline, concanavalin-A (Con A), purified
protein derivative (PPD) of Mycobacterium tuberculosis, Ova,
or renal antigens. Results were expressed as a stimulation index
obtained by dividing the test sample (counts per minute) by the
saline (background) result. Assays were performed in triplicate
and the results averaged.
Characterization of renal mononuclear cell infiltrates. Indi-
rect IF microscopy [25] was used in association with murine
monoclonal antibodies (Sera Labs, Crawley, UK) 0X19, a
specific pan T cell reagent, W3/25 reacting with T helper cells
and some macrophages, 0X8 marking cells of the T-cytotoxic/
suppressor cell subset and some natural killer cells and 0X6
reactive with Ia expressing cells [26—351. A fluoresceinated goat
F(ab')2 anti-mouse IgG (absorbed with rat serum) (Cappel
Laboratories, Downington, Pennsylvania, USA) was used as
the second reagent. Control sections were incubated with
hybridoma—induced ascites fluid of unrelated antibody speci-
ficity.
Adoptive transfer of immune cells from LEW rats immunized
with BN RBM and adjuvants
Single cell suspensions of LNC from draining lymph nodes
were prepared as described above. Splenic cells were isolated
by teasing the spleen with tissue rakes and pressing through a
wire mesh. After hemolysis of red blood cells with Tris—buf-
fered ammonium chloride pH 7.0, 0.83%, the mononuclear cells
were washed three times with RPMI-1640 and viability assessed
by trypan blue exclusion. 3.5 to 7 x 108 LNC and/or splenic
cells suspended in 1 to 1.5 ml RPMI-l640 were injected intra-
venously into naive LEW recipients. In some experiments B
cells were depleted by "panning" [361 using affinity—purified
anti-rat IgG. Control LEW rats were injected with either 1)
immune cells from LEW rats immunized with Ova and adju-
vants 14 days previously, or 2) irradiated (3000 rads) immune
cells from LEW rats immunized with BN RBM and adjuvants
14 days previously, or 3) immune cells from LEW rats immu-
nized with Ova and adjuvants after a two hour incubation with
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Table 1. Time cour
immu
se study of the development of TIN in LEW rats
nized with BN RMB and adjuvants
Days after
immunization Rats with TIN TIN serveritya
8 0/4 0
9 3/4 1.3 0.3
11 4/4 3.0±0.4
14 14/14 4.8 0.1
21 15/15 3.5 0.1
28 10/10 2.6 0.2
a Histological lesions graded on a scale of 0 to 5 (Methods) and
expressed as mean SEM
BN RBM. Renal tissue obtained at nephrectomy or sacrifice
was prepared for histology and IF examination. Reactivity of
the recipient sera with RBM or CS-RBM was assessed by solid
phase RIA at 7 or 14 days, after adoptive transfer.
Statistical analysis: Student's t-test was used to analyze
differences between groups.
Results
Fig. 1. Discrete raised nodules over the surface of a kidney at day 14
from a LEW rat immunized with BN RBM, CFA and pertussis vaccine.
(magnification x4)
Preliminary dose—response studies
Groups of three LEW rats were immunized with 100 sg, 500
g, I mg, 2 mg, 4 mg, and 8 mg of BN RBM and adjuvants and
sacrificed at day 15. Most animals immunized with 1 mg or more
of RBM developed grade 5 disease, that is, grossly visible
nodules covering over 30% of the kidney surface. Rats receiv-
ing 500 g developed grade 3 or 4 disease, involving an average
of 20% of the cortex, while 100 g immunization was not
sufficient to cause any lesions. An immunizing dose of 4 mg per
rat was selected for the remainder of the studies.
Time—course studies
Table 1 shows the development of the lesions of TIN in the
LEW rat with increasing time after immunization with 4 mg BN
RBM and adjuvants. Kidneys from at least four rats were
examined at each time point. Mild, focal mononuclear cell
infiltration between tubules was first evident at day 9, increas-
ing thereafter until day 21. No consistent influx of polymorpho-
nuclear leukocytes was observed. By days 12 to 14, over 35% of
the cortical surfaces of kidneys of most immunized rats were
involved with very characteristic focal nodular circumscribed
lesions which could be seen on gross examination (Fig. I), and
which histologically had a somewhat granulomatous appear-
ance with a central area containing epithelioid cells and occa-
sional multinucleate giant cells with a surrounding infiltrate of
mononuclear cells (Fig. 2A, B). These focal inflammatory
lesions always had collapsed and severely damaged tubules in
their centers. Periglomerular infiltration was common with
occasional breaks in Bowman's capsule and entry of mononu-
clear cells into Bowman's space. However, the glomerular tuft
usually remained intact. Although most lesions were cortical,
scattered nodules could also be found in medullary areas. By
days 21 to 28, focal mononuclear cell infiltrates decreased,
leaving small areas of scarring in the cortex with dilated
tubules, peritubular fibrosis, and increased numbers of giant
cells (Fig. 2C). At a much later time point (day 55), giant cells
disappeared and many glomeruli, surrounded by cellular infil-
trates, appeared obsolescent.
IF studies showed an absence of TBM or GBM IgG fixation
on days 5 to 14, except in occasional areas of inflammation,
where portions of TBM showed linear IgG staining (Fig. 2D) at
day 14. Of interest, at later time points (days 21 and 28), some
rats (5 of 8) showed weak to moderate linear GBM and rarely (1
of 8) low intensity diffuse (cortical and medullary) TBM IgG
staining, in addition to occasional brighter, linear TBM fixation
in inflammatory areas. This indicated the occasional emergence
of an additional form of auto-anti-basement membrane antibody
different from the alloreactive LEW anti-BN TBM response
seen in all BN RBM immunized LEW rats. This GBM, TBM
reaction pattern in the LEW rat can also be produced with
human anti-GBM antibodies present in Goodpasture's syn-
drome by indirect immunofluoresence using LEW kidney sec-
tions (Wilson CB, unpublished observations). In addition, at
day 55, in 3 of 3 rats, finely granular IgG deposits could be
detected along the GBM as presumed Heymann's type glomer-
ulonephritis developed. C3 was present in focal, segmental
deposits on unaffected TBM, but in a circumferential linear
pattern around tubules within areas of inflammation at days 12
to 14. Circumferential C3 was not found at time points preced-
ing the fully developed nodular, inflammatory lesions. GBM C3
deposits were not found at any time point examined prior to day
55.
Controls
Twelve normal LEW rats were immunized with Ova (200 .Lg)
and adjuvants in the same manner as the experimental group
and examined histologically (12 rats) and by IF (6 rats) at day
14. No lesions of TIN were detected by light microscopy and IF
did not show GBM or TBM fixation of IgG. C3 was found in a
focal, segmental distribution along TBM. Mild, mononuclear
cell infiltrates were noted in the lungs of some CFA-injected
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Fig. 2. Interstitial infiltrates in kidney sections from LEW rats immunized with BN RBM, CFA and pertussis vaccine. A. (magnification x120) A
day 14 nodular, granuloma—like cellular infiltrate containing a multinucleate giant cell (arrow) (G = glomerulus), with a higher power field
(magnification X350) of the giant cell in B. At day 21(C) (magnification x350) more giant cells and increasing fibrosis (arrow) are seen in the
inflammatory infiltrate (periodic acid Schift). Segmental linear TBM staining (arrow) is seen on a damaged tubule involved in an inflammatory
infiltrate (D) at day 14. (Fluorescein isothiocyanate—conjugated anti—rat IgG) (magnification x250). E A majority of infiltrate cells stained with the
monoclonal antibody 0X6 and fluorescein isothiocyanate-conjugated F(ab')2 anti-mouse IgG. (magnification X600)
646 Bannister et a!
Table 2. Elution studies of kidneys from LEW rats immunized with
BN RBM and adjuvants
Eluate/ Eluate im-
Time after im- Kidneys
Eluted IgG
gIg
seruma
(anti-LEW
munofluores-
cenceb LEW
munization eluted kidney RBM) target
Day 14
(BN RBM)C 2 (1 rat)
2 (1 rat)
2(1 rat)
2(1 rat)
2(1 rat)
2.4
0.6
1.9
1.2
2.1
19.5
3.5
1.9
2.2
2.0
2+
0
0
Day 14 (Ova)0 2(1 rat)
2(1 rat)
2(1 rat)
3.0
6.9
7.4
1.9
1.3
1.2
0
0
Day 14
(BN RBM)0 20 (10 rats) 1.1 5.2
Day 28
(BN RBM)0 16 (8 rats) 2.0 20.0 1+
a Particulate LEW RBM reactivity of serum and eluates
compared with reference to lgG content. Serum and eluates from
control rats immunized with Ova were tested by RIA against Ova
' Reactivity of kidney eluates tested on normal LEW kidney sections
and linear GBM/TBM staining graded on a scale of 0 to 3+
Immunogen
animals. Livers and spleens of experimental and control rats
were histologically normal.
Elution studies
In view of the IF findings of occasional late development of
autoreactive anti-GBM/TBM antibodies, kidneys from five in-
dividual immunized LEW rats were eluted at day 14 in addition
to elution of 20 pooled kidneys at day 14 and 16 pooled kidneys
at day 28. Table 2 shows the amount of IgG eluted from control
(Ova immunized) and the individual and pooled experimental
rat kidneys. Although only minimal amounts of IgG were
eluted, one of five BN RBM immunized LEW rats showed a
selective concentration of anti-LEW RBM antibody in the
eluate compared to serum at day 14 by RIA, and this eluate
reacted with GBM and TBM of a normal LEW kidney section.
In addition, the eluate of pooled day 28 kidneys reacted with
normal LEW GBM and TBM in a linear fashion, and also
showed a selective concentration of anti-LEW RBM antibody
over serum. In contrast, the eluate from day 14 pooled kidneys
did not show a significant eluate/serum ratio change and did not
fix to LEW kidney.
Functional studies
Serum creatinine levels (mg/dl) were significantly elevated in
11 male LEW rats immunized 14 days previously with BN RBM
(1.13 0.11; P < 0.01) compared to 10 day 14 Ova-immunized
male control rats (0.60 0.03). By day 28, however, mean
serum creatinine levels were no longer significantly different
(0.47 0.05; P> 0.05) when compared to the control group.
There was no significant difference in 24 hour urinary protein
excretion (mg) between day 14(1.68 0.4), day 28 (1.53 0.6)
experimental rats, and day 14 Ova-immunized controls (1.55
0.3). In addition, glucose was not found in any of the urine
samples.
on RIA
Table 3. The effect of the source of RBM on the development of TIN
in LEW rats immunized with homologous or heterologous RBM and
adjuvants
Circulating
Source of
RBM
Rats with TIN
(day 14)
TIN
severityb
anti-BN TBM
antibodyc
Homologous
BN (+) 14/14 4.8 0.1 +
LBNFI (+) 2/2 5.0, 5.0 +
ACt (+) 2/2 4.0, 5.0 +
BUFF (+) 2/2 4.0, 5.0 +
WK (+) 2/2 4.0, 5.0 +
SD (+) 2/2 5.0, 5,0 +
LEW (—) 1/Il 1.0 —
WM (—) 1/4 2.0 —
WF(—) 0/4 0 —
Heterologous
Bovine (+) 7/8 2.1 0.4 +
Bovine
KBr(+) 1/5 1.0 +
Human (+) 3/3 1.7 0.3 +
Rabbit (+) 9/9 1.6 0.2 +
Control
Ova 0/10 0 —
a Immunization was achieved using 4 mg of each immunogen except
for bovine KBr, a soluble chaotropic extract of particulate bovine TBM
[71 used at a dose of 200 pg/rat, and Ova used at 200 jzglrat. All animals
also received CFA and pertussis vaccine. TBM Ag status given in
b Histological lesions graded on a scale of 0 to 5 (Methods) and
expressed as mean SEM
Circulating anti-BN TBM antibody was detected by IF using normal
BN kidney sections
The effect of the source of the immunogen on TIN in LEW
rats immunized with RBM and adjuvants
The results in Table 3 demonstrate the effect of the source of
the RBM used to immunize LEW rats. Homologous TBM Ag
RBM immunogens resulted in macroscopically visible disease
of the same nature as that induced with BN RBM. Homologous
or autologous TBM Ag RBM usually caused no disease or
very small focal lesions at best. Heterologous TBM Ag RBM
immunization caused similar but quantitatively less severe
disease than homologous TBM Ag immunization. IF exami-
nation of the diseased kidneys of the various TBM Ag RBM
immunized LEW rats at day 14 showed occasional diffuse
tubular cytoplasmic reactivity which was not further character-
ized with an absence of GBM or TBM antibody fixation, except
for some focal TBM staining in areas of inflammation as seen
with BN RBM immunization.
The humoral immune response in LEW rats immunized with
RBM and adjuvants
Indirect IF. Sera from LEW rats immunized with BN RBM
reacted with a normal BN kidney target with linear IgG fixation
along most, but not all, cortical TBM and occasionally along
Bowman's capsule. This reactivity was detectable by day 7
after immunization, and at day 14 was present at a 1/12,800 titer
in pooled sera from 80 rats. The sera did not react with BN
medullary TBM and GBM except in the case of serum from 1 of
4 rats at day 21 after immunization; this serum also reacted with
LEW GBM and medullary TBM in a linear fashion. Serum from
LEW rats immunized with TBM Ag RBM (LEW, WF, WM)
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Fig. 4. The ability of various homologous and heterologous RBM
preparations to inhibit the binding of a LEW anti-BN RBM serum pool
to BN-CS-RBM by solid phase radioimmunoassay was tested. Values
represent the average of samples run in triplicate.
did not react with TBM or GBM of either LEW or BN kidney.
Heterologous (human, rabbit, bovine) RBM immunization of
LEW rats produced circulating alloantibody which fixed to
TBM of BN rat kidney but not LEW TBM.
Table 4. Blast transformation assays of LNC from LEW rats
immunized 14 days previously with BN RBM and adjuvants
Antigen (RBM)
or mitogena
Number of
rats studied Stimulation indexb
BN
BUFF
F344
8
4
4
56.8 14.7
22.5 15.0
20.9 14.5
LEW
WF
8
4
1.4 0.4
1.0±0.1
Con A
Ova
PPD
8
8
8
59.3 15.4
3.2 0.7
70.7 11.8
a Blast transformation of LNC from individual rats measured in
response to antigen or mitogen after 5 day culture by incorporation of
titriated thymidineb Stimulation index obtained by dividing test sample result by the
saline (background) result and expressed as mean SEM
Table 5. Adoptive transfer experiments using immune cells from
LEW rats immunized 14 days previously with BN RBM and
adjuvants
.Cell population
transferred
No. of cells
transferred
.Rats with
TIN
TIN severitya
Day 7 Day 14
BN RBM
immunized
LNC
Spleen
3.5—6 x 108
4—7 x 108
6/6
4/5
2.0 0.5
1.5 0,3
1.7 0.2
1.7 0.3
LNC + spleen 3.5—6 x 108 9/9 3.2 0,4b 1.3 0.3c
LNC + spleend 2.5—4 x 108 2/2 1.0 0.0 NT
LNC + spleen 4 x 10 0/3 0 NT
Serum alone1 0/3 0 NT
Ova immunized
LNC 3—6 x 10 0/3 0 0
Spleen 6 x 108 0/2 0 0
LNC + spleen8 4 x 108 0/4 0 NT
TBM Ag a Histological lesions graded on a scale of 0 to 5 (Methods) and
expressed as mean SEM
b 6/8 rats with TIN
c 3/3 rats with TIN (including 2 rats without TIN at nephrectomy on
day 7)
d B cell depleted (<4%) by "panning" on petri dishes coated with
affinity purified anti-rat IgG
Irradiated (3000 rads) prior to transfer
Two LEW rats received 7 ml and one rat 3 ml of serum from LEW
rats immunized 14 days previously with BN RBM and adjuvants
Incubated with BN RBM (5 mg/4 x 108 cells) for 2 hrs prior to
TBM A * transferg NT = not tested
12
10
— —— -
A—I
I
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Fig. 3. The binding of pooled sera from LEW rats at various rime points
after immunization with BN RBM and adjuvants was tested by solid phase
radioimmunoassay using particulate LEW RBM (A), LEW-CS-RBM (0),
particulate BN RBM (A), and BN-CS-RBM (•) antigens. The values
represent the average of samples run in triplicate from which the binding
of pooled sera from non-immunized LEW rats was subtracted.
0
x
Ea0
g Inhibitor
RIA. The humoral immune reaction to particulate BN RBM
and BN-CS-RBM rose rapidly from day 5 and continued to rise
through day 28 (Fig. 3). Serum from immunized LEW rats also
contained an autoantibody reacting with LEW particulate RBM
and CS-RBM, although at much lower levels than BN RBM
reactivity, and decreasing by day 28 (Fig. 3). There was little
difference in serum reactivity after immunization with I mg, 2
mg, 4mg, or 8 mg of BN RBM when tested at day 14 against BN
particulate or CS-RBM. However, lower levels occurred after
immunization with 500 g or 100
.tg BN RBM. Selective
inhibition of BN-CS-RBM reactivity of serum from LEW rats
immunized with BN RBM with various homologous and heter-
ologous RBM is shown in Figure 4. The immunizing antigen and
other homologous TBM Ag RBM produced most inhibition,
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Fig. 5. Granuloma—like cellular infiltrate in A with multi-nucleate giant cell (arrow) at day 7 in the kidney of a LEW recipient of adoptively
transferred immune cells taken from LEW rats immunized with BN RBM, CFA, and pertussis vaccine. (magnification x 120). B. A higher power
field around the giant cell (G = glomerulus) (Periodic acid Schiff). (magnification x230)
with homologous TBM AgRBM barely inhibiting BN-CS-
RBM reactivity at all. Heterologous TBM Ag RBM resulted in
intermediate levels of inhibition.
The cellular immune response in LEW rats immunized with
BN RBM and adjuvants
Blast transformation of LNC in response to renal antigens.
LNC from immunized LEW rats incorporated thymidine in
response not only to the immunizing antigen (particulate BN
RBM) but also to other TBM Ag RBM (Table 4). In contrast
there was only minimal blast transformation after stimulation
with autologous RBM or with another TBM Ag RBM.
Characterization of renal mononuclear cell infiltrates. Virtu-
ally all the cells within inflammatory foci stained with the 0X6
reagent, a monoclonal antibody reacting with the Ia antigen
(Fig. 2E). The large, epithelioid cells in the center of the
inflammatory foci did not stain with pan T cell (OX 19) or T cell
subset (W3/25, 0X8) monoclonals, but 50 to 60% of the
surrounding mononuclear cells were positive with OX19 and
W3/25 (T-helper) reagents, with only 1 to 5% being 0X8
(T-suppressor) positive cells. IgG cells made up less than 5%
of the cell population.
Adoptive transfer of LNC from LEW rats immunized with BN
RBM and adjuvants to naive LEW recipients
Intravenous transfer of day 14 immune cells (spleen and/or
LNC) to normal LEW rats resulted in renal interstitial cell
infiltration in 21 of 22 recipient animals tested (Table 5). No
histological lesions were seen after transfer of any control cells,
including the irradiated immune cells, strongly suggesting that
transfer of antigen was not responsible for these lesions. The
extent of the TIN varied considerably, being greatest after LNC
plus splenic cell transfer. At the earliest time point examined
(day 7), severe focal tubular destruction was often present along
with frequent giant cells and mononuclear cell infiltrates (Fig.
5). Histologically the lesions were essentially the same as day
14 to 21 lesions in the active model. IF studies did not
demonstrate fixation of antibody to TBM or GBM in recipient
kidneys. By RIA circulating antibody reactive with BN and
LEW RBM could be detected at day 7 after cell (LNC or
spleen) transfer. However, the levels of these allo- and 4uto-
antibodies were less than those induced by 100 g BN RBM
immunization in the active model (data not shown), an immu-
nizing dose incapable of causing TIN. Characterization of the
inflammatory infiltrates in the recipient kidneys using monoclo-
nal antibodies again showed virtually all cells stained with 0X6
(anti-Ia) with the same proportions of T cells and T cell subsets
as in the active model and minimal numbers of B cells (IgG).
Discussion
This study of an unique model of autoimmune TIN in the
LEW rat has clearly demonstrated a pathogenic role for im-
mune cells in the initiation of TIN in this strain. Previous
reports have suggested that cell—mediated immunity may play a
role in the pathogenesis of TIN in the BN rat and guinea pig
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[10—14, 25], but adoptive transfer of TIN with immune cells
injected intravenously has been unsuccessful [6—8]. Mild lesions
were produced after subcapsular transfer of immune cells in the
BN rat [9]. Minor lesions were reported 24 to 48 hours after
intravenous transfer to normal LEW recipients of immune cells
from LEW rats previously immunized with LEW kidney ho-
mogenate [21]. However, we were able to induce only very
minor cellular infiltrates in LEW rats after immunization with
syngeneic RBM and adjuvants.
In the present study, the lack of in vivo fixation of antibody
to LEW TBM at the time of the developing disease and the
successful transfer of the full—blown histologic lesions using
immune cells strongly suggests that cell—mediated immunity
plays a central role in TIN in the LEW rat. Of interest, we have
found that passive transfer of the alloreactive anti-TBM anti-
body from immunized LEW rats to normal BN recipients
resulted in the development of lesions of TIN in as little as 24
hours, confirming an initiating role for anti-TBM antibody in
TIN in the BN rat [5].
The development of TIN in the LEW rat appears to be
dependent on the source of the immunogen. A necessary
requirement was the expression of the IF detectable TBM
antigen by the kidney from which the immunogen (RBM) was
derived. Thus, RBM from LEW, WM, and WF rats (TBM Ag)
induced only very minor or more usually no lesions of TIN in
the LEW rat. Homologous TBM Ag RBM immunization
always resulted in severe TIN with functional renal impairment
in the case of BN RBM, whereas heterologous RBM which
contained relatively lower amounts of the TBM antigen, as
shown by inhibition RIA, produced only mild lesions of TIN in
LEW rats. Our laboratory in the past and others have not
observed the induction of the LEW TIN using homologous [20]
or heterologous [19, 37] TBM Ag basement membrane. Our
findings of minor lesions in LEW rats in our present study may
relate to differences in antigen preparation or perhaps to slight
differences in adjuvant mixtures used to promote the immune
response.
Blast transformation studies of LNC from immunized LEW
rats showed the presence of cells sensitized to the TBM antigen
but not to autologous RBM antigens. Although this finding
correlates with the relevance of the TBM antigen in producing
TIN in the LEW rat, the lack of stimulation by LEW RBM was
surprising, as the presence of cross—reactive TBM determinants
in the immunogen and on host basement membrane was con-
sidered to be a likely pathogenic mechanism of TIN, especially
as these LNC were capable of adoptive transfer of disease to
LEW recipients. However, in a study of isolated intrarenal
infiltrate cells from BN rats immunized with bovine TBM, a
similar lack of response to autologous renal antigens was also
observed [7], suggesting either that the population of specifi-
cally sensitized cells in the larger inflammatory infiltrate may be
undetected due to suppressor mechanisms or that the assay
system (or antigens used) may be inappropriate.
The histologic lesions developed by the LEW rats after
immunization differed from the more diffuse anti-TBM anti-
body—mediated lesions seen in the BN rat after immunization
with heterologous [7, 19, 20, 37, 38] or homologous [4] TBM, or
after passive transfer of LEW anti-BN RBM serum [5]. The
nodular, granuloma—like nature of the cellular immune LEW
lesions has a parallel in drug—induced TIN in humans, in which
granuloma—like lesions have been described in a number of
cases related to methicillin or thiazide—like diuretics [39—41]. As
has been reported in human TIN [42, 43], virtually all of the
cells infiltrating the interstitium of the LEW kidney stained with
an anti-Ia monoclonal antibody. Many of these cells expressed
T-helper cell markers, suggesting T cell activation in the inflam-
matory lesions. This same pattern has also been reported in
TIN in the BN rat [7] and in experimental allergic encephalo-
myelitis (EAE) in the LEW rat, an autoimmune disease felt to
be T cell mediated [44].
Of interest, linear IgG staining was occasionally found on
segments of damaged TBM in areas of inflammatory infiltrates
in the LEW kidneys. Previous work in our laboratory has
shown that LEW-CS-TBM does contain small amounts of the
TBM antigen reacting with BN anti-TBM antibody in inhibition
RIA studies [22], suggesting that exposure of these antigens
may occur in LEW TBM in the presence of enzymes related to
the inflammatory process. Perhaps some of the low—level anti-
LEW TBM reactivity detected in this study by RIA using LEW
TBM fragments or collagenase digests has a similar basis. The
significance of the linear C3 deposition in areas of inflammatory
infiltrate at days 12 to 14 is unknown, but complement fixation
was not seen at any earlier time point, suggesting that deposi-
tion may be secondary to tubular damage.
Although the LEW rat quantitatively lacks the "classical"
BN type TBM antigen(s), it does, as would be expected,
express other TBM (and GBM) antigens that are less well
defined. A very small number of LEW rats in this study
developed circulating and bound autoantibodies reactive with
LEW GBM and TBM (primarily medullary) after immunization
with BN RBM. In preliminary studies, immunization with one
preparation of homologous RBM resulted in a high percentage
of LEW rats which developed this antibody system, and in vivo
and in vitro alveolar basement membrane fixation of the anti-
body was also found (Bannister KM, and Wilson CB, unpub-
lished observations); the antibody reacted with the nephritoge-
nic GBM antigens of human Goodpasture Syndrome by RIA
[45]. In addition, LEW rats immunized with LEW-CS-RBM
and adjuvants also developed similar antibodies reactive with
LEW GBM and TBM (Bannister KM, and Wilson CB, unpub-
lished observations). This antigen—antibody system, shared by
both GBM and TBM, appears to be similar to the antigens
involved in human anti-GBM disease, and may have similarities
to those reported by Robertson, Hill and Rowlands [38] after
immunization of BN rats with heterologous GBM and TBM
preparations, as well as those induced with mercuric chloride
[46]. The fixation of these anti-GBM/TBM antibodies tended to
occur much later (day 28) than the development of the his-
tologic lesions of TIN in the LEW rat, suggesting that these
antibodies were not related to the induction of TIN in these
rats.
In conclusion, we have described an unique model of nodular
TIN in LEW rats which, by virtue of its transferability by
immune cells alone, has provided clear evidence for an initiat-
ing role for cell—mediated immunity in TIN in this strain. The
histologic similarity of this lesion and some forms of drug
induced TIN in humans suggests that this model may be useful
for advancing our understanding of the human disease.
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